Mi-2β promotes immune evasion in melanoma by activating EZH2 methylation.
Saved in:
| Title: | Mi-2β promotes immune evasion in melanoma by activating EZH2 methylation. |
|---|---|
| Authors: | Li C; Skin Disease Research Institute, The 2nd Hospital and School of Medicine, Zhejiang University, Hangzhou, 310058, China.; Research Center for Life Science and Human Health, Binjiang Institute of Zhejiang University, Hangzhou, 310053, China., Wang Z; Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Science, Little Rock, AR, 72205, USA., Yao L; State Key Laboratory of Molecular Oncology, School of Pharmaceutical Sciences, Tsinghua-Peking Center for Life Science, Tsinghua University, Beijing, 100084, China., Lin X; Zhuhai Yu Fan Biotechnologies Co. Ltd, Zhuhai, Guangdong, 51900, China., Jian Y; School of Life Sciences, Henan University, Kaifeng, 475000, China., Li Y; School of Life Sciences, Henan University, Kaifeng, 475000, China., Zhang J; National Key Laboratory for Novel Software Technology, Nanjing University, Nanjing, Jiangsu, China., Shao J; National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, International Academy of Targeted Therapeutics and Innovation, College of Pharmacy, Chongqing University of Arts and Sciences, Chongqing, 402160, China., Tran PD; Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Science, Little Rock, AR, 72205, USA., Hagman JR; Department of Immunology and Genomic Medicine, National Jewish Health, Denver, CO, 80206, USA., Cao M; Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China., Cong Y; Key Laboratory of Aging and Cancer Biology of Zhejiang Province, Hangzhou Normal University School of Basic Medical Sciences, Hangzhou, 310058, China., Li HY; Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Science, Little Rock, AR, 72205, USA. lih1@uthscsa.edu., Goding CR; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Headington, Oxford, OX3 7DQ, UK. colin.goding@ludwig.ox.ac.uk., Xu ZX; School of Life Sciences, Henan University, Kaifeng, 475000, China. 10140187@vip.henu.edu.cn., Liao X; State Key Laboratory of Molecular Oncology, School of Pharmaceutical Sciences, Tsinghua-Peking Center for Life Science, Tsinghua University, Beijing, 100084, China. liaoxuebin@mail.tsinghua.edu.cn., Miao X; Department of Dermatology, Shuguang Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China. 0000002623@shutcm.edu.cn.; The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Jiangxi Medical College, Nanchang University, Nanchang, China. 0000002623@shutcm.edu.cn., Cui R; Skin Disease Research Institute, The 2nd Hospital and School of Medicine, Zhejiang University, Hangzhou, 310058, China. rutaocui@zju.edu.cn. |
| Source: | Nature communications [Nat Commun] 2024 Mar 09; Vol. 15 (1), pp. 2163. Date of Electronic Publication: 2024 Mar 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-024-46422-5 |
